News

CART News Archives

Chuanhai Cao – University of South Florida ($50,000 Grant)

Posted by on Sep 17, 2014 in News | 0 comments

Chuanhai Cao – University of South Florida ($50,000 Grant)

On May 6, 2014, at the annual meeting of The CART Fund, Chuanhai Cao, Ph.D., Assistant Professor, College of Pharmacy, Department of Pharmaceutical Science, was awarded a CART grant in the amount of $50,000.

Research Project

There is a need to develop new and effective treatments to combat the devastating neurodegenerative disorder Alzheimer’s Disease (AD). [...]

read more

Dr. Allan Levey Receives NIH AD grant for $7.2M

Posted by on Sep 17, 2014 in News | 0 comments

Dr. Allan Levey Receives NIH AD grant for $7.2M

  Dr. Allan Levey, MD, Ph.D., of Emory University, has received a grant from the National Institutes of Health (NIH) for $7.2M for Alzheimer’s disease research.  The purpose of this study is to discover proteins ‘beyond the usual suspects of beta-amyloid and tau’ that are altered by Alzheimer’s disease, in an effort to identify new […]

read more

Early AD Diagnosis with Retinal Scans – Dr. Maya Koronya-Hamaoui, Cedars-Sinai

Posted by on Sep 17, 2014 in News | 0 comments

Early AD Diagnosis with Retinal Scans – Dr. Maya Koronya-Hamaoui, Cedars-Sinai

  Exciting progress on an effort to diagnose Alzheimer’s Disease with retinal scans was announced at the Alzheimer’s Association International Conference in Denmark in July 2014. This safe, early, non-invasive diagnosis of Alzheimer’s using retinal scans is based on the research of 2012 CART grant recipient Dr. Maya Koronyo-Hamaoui of Cedars-Sinai Medical Center. NeuroVision Imaging […]

read more

Dr. Kurt Brunden

Posted by on Nov 14, 2011 in News, Uncategorized | 0 comments

Dr. Kurt Brunden

Research Associate Professor Scientific Director, Marian S. Ware Alzheimer and Benaroya Parkinson’s Disease Drug Discovery Programs Dr. Burnden’s proposal is close behind Puglieli’s in terms of proximity to animal model testing, after Brunden does some toxicology. Brudens proposal focuses on a family of aminothienopyridizine (ATPZs) compounds that emerged from 290,000 compound screens for drugs to […]

read more